Recommendation

NO POSITION. The single variable that determines bull vs bear — Lanteris segment margins — is unverifiable until Q4 2025 earnings (Mar 23, 2026). Pre-earnings positioning is a bet on an unverifiable management claim against a mixed historical base rate. That's gambling, not edge.

Mild bearish lean from positioning asymmetry: consensus is 7:1 bullish against a roughly 50/50 binary, with 2-3:1 downside/upside skew on a miss vs beat. Not actionable pre-catalyst, but not neutral either.

Re-evaluate after Mar 23 disclosure. Specific trigger: GAAP operating margin for Lanteris segment. Secondary trigger: whether they disclose segment margins at all.

What the Market Requires

At $17.55, the stock prices in:

• Combined revenue $850M+ in FY2026 (management guided)
• Lanteris "double-digit EBITDA margins" (management claimed, unverified)
• Multiple program wins: LTVS Phase 2, NSNS follow-on, Golden Dome participation
• No significant dilution beyond known convertible/Advent overhang
• Government funding stability under DOGE-era budget scrutiny

Consensus is 7:1:1 Buy/Hold/Sell. Median target $18.00 — the market is already AT consensus. Forward P/E 357x. Implied vol 177% (97th percentile). The options market is pricing a binary.

The One Variable That Matters

Everything reduces to Lanteris margins.

Historical base rate (Maxar 10-K, filed 2023-02-22):

The Space Infrastructure segment — the exact business Advent carved out, renamed Lanteris, and sold to LUNR for $800M — reported:

Management now claims "double-digit EBITDA margins."

The right base rate matters. FY2022 (-5.1%) was the worst year — revenue dropped $114M while the segment was being carved out for sale. Distressed asset in transition. FY2021 (6.2%) was the last normal operating year. If Advent improved margins from a 6.2% base to 10%+, that's a 4-8 percentage point swing — squarely within normal PE restructuring (headcount reduction, overhead stripping, contract renegotiation, unprofitable program pruning). Not a miracle. If you anchor to FY2022, management needs a 15-20pp swing and the claim looks heroic. If you anchor to FY2021, they need 4-8pp and the claim looks plausible.

We still can't verify which. Lanteris is private. No public financials exist between FY2022 and the Q4 2025 filing due Mar 23. The claim is management's word, unverifiable by any primary source.

Advent paid $6.4B total for Maxar. Space Infrastructure was the problem child — Earth Intelligence was the crown jewel at 30%+ margins. The most natural reading is that Advent bought Maxar for Earth Intelligence, restructured Space Infrastructure enough to make it sellable, and offloaded it to LUNR at a price that reflects improved margins in the achievable range. Whether "improved" means 8% (modest restructuring) or 12% (aggressive restructuring) is the entire question.

If margins are genuinely double-digit: combined entity generates $80-100M+ EBITDA, stock is worth $18-22, current price is fair.

If margins are low-single-digit with adjusted add-backs: combined entity is marginally profitable or cash-burning, $800M acquisition looks overpriced, stock is worth $8-12.

The range is $8-22 depending on one variable we can't verify for 28 days.

What Primary Sources Actually Show

Seven stages of research, primary sources only. Here's what survived.

The acquisition structure ($800M):

• $450M cash + $350M stock at $12.34/share (8-K, Jan 13, 2026)
• Advent receives 22.99M shares with registration rights for 3 underwritten secondaries + piggyback rights
• ING Belgium orbital receivables purchase facility inherited (through Dec 2026)
• Transaction bonuses: CEO $512K, CFO $247K (8-K, Feb 11, 2026)

The balance sheet (10-Q, Q3 2025, pre-close):

• Cash $622M (includes $335M net convertible proceeds)
• Convertible notes: $345M at 2.5%, conversion $13.11/share, capped call cap $20.98, 26.3M shares
• Accumulated deficit: -$996.5M at FY2024, improved to -$370.7M at Q3 2025 (accounting, not cash)
• Remaining performance obligations: $119.3M, backlog $235.9M

Revenue reality (10-Q, 9M 2025):

• Standalone LUNR: $165.3M revenue (9M), operating loss -$54.1M
• G&A up 32% to $52.4M (acquisition costs flowing through)
• Operating cash flow: -$57.6M (9M)
• This is the pre-acquisition entity. Post-acquisition numbers don't exist yet.

SDA bus revenue (confirmed, not quantified):

• Lanteris supplies 300 Series satellite buses to L3Harris for SDA Tranches 1, 2, and 3
• L3Harris Tranche 3 tracking layer: $843M for 18 satellites (≈$47M/unit)
• Bus typically 25-40% of satellite cost = est. $12-19M/bus, est. $216-342M Tranche 3
• L3Harris never mentions Lanteris by name in any transcript or filing
• Relationship is real and contractual. Dollar magnitude is estimated.

Golden Dome — optionality, not revenue:

• Searched 25+ Q4 2025 earnings transcripts across defense/space sector
• LUNR mentioned by ZERO counterparties in connection with Golden Dome
• No contract, no subcontract, no teaming agreement in any filing
• Management mentions it as "opportunity" — that's not revenue, it's aspiration
• But the market is pricing some optionality here. With 177% IV and 7:1 buy/sell, Golden Dome is part of the narrative premium. Honest quantification: P(meaningful subcontract in 12-18mo) ≈10-15%. Plausible contract value $100-300M multi-year. Expected value: $10-45M, or 0.4-1.8% of market cap. Not zero, but not material to the thesis. The market is pricing Golden Dome as a bigger option than the evidence supports — zero counterparty mentions is a strong prior against near-term materialization.

LTVS — competitive, not awarded:

• "Expect LTVS demonstration awarded... government put timing question" (CEO, Q3 transcript)
• 1-of-3 competitive selection. Timing unclear. Not in backlog.

Counterparty Cross-Reference

The other side of every claimed relationship:

The silence from counterparties is informative. When L3Harris discusses SDA wins worth billions, they don't name their bus supplier. Either the bus is commodity (replaceable) or the dollar value is immaterial to L3Harris ($47B market cap). Neither interpretation is bullish for Lanteris pricing power.

Factor Decomposition

iev regress LUNR (pre-acquisition standalone):

Below 75% idio target. Nearly half the variance is momentum. This is a momentum stock, not an idiosyncratic story — at least based on pre-acquisition trading history.

Caveat: This regression uses pre-acquisition LUNR. The combined entity is fundamentally different ($165M standalone → $850M+ combined revenue). No valid regression can be run until Q1-Q2 2026 data accumulates. RKLB as proxy shows similar factor profile (64% idio, 49% momentum) but +99.8% alpha — confirming factor structure is sector-wide but alpha is stock-specific. The regression is broken for sizing purposes.

Edge audit on each factor:

• Momentum (+4.05 beta): NO edge. Can't predict momentum reversals.
• Market (-2.65 beta): NO edge. Negative beta is unusual, probably artifact of SPAC-era trading.
• Industrials (+1.03 beta): NO edge on sector direction.
• Idiosyncratic (65.9%): This is where edge WOULD live. But can't calculate idio alpha without verifiable Lanteris margins.

Positioning and Forced Actors

Who is forced to buy if right:

• Short sellers: 17.4M shares short, 21% of float, 2.2 days to cover
• Convertible arb desks: hedged short above $13.11, forced to cover on sustained move above $20
• Momentum algos: stock above 50D and 200D MA, breakout above $20 triggers systematic buying

Who is forced to sell if wrong:

• Advent International: 22.99M shares, registration rights, PE fund with LP return timeline
• Convertible arbitrageurs: if stock drops below $13, convert goes out-of-money, forced delta unwind
• Margin longs: 177% IV = high margin requirements, any drawdown triggers forced selling
• CEO/CFO/CTO: actively selling every award immediately (Feb 11-13 filings show $2.6M in officer sales)

Convertible mechanics create a ceiling, not a floor:

The capped call (strike $13.11, cap $20.98, 26.3M shares) means dealers are short the $13.11 call and long the $20.98 call. Above $20.98: dealers sell stock (long call hedge) = mechanical ceiling. This is well understood.

The floor question is more nuanced. Near $13.11: two offsetting forces. Convert arb desks (long bond, short delta shares) cover shorts as stock drops toward conversion price = buying pressure. But capped call dealers (short $13.11 call, negative gamma) sell delta as stock falls through $13 = selling pressure. These roughly cancel around $13. No strong mechanical floor from the convert.

The real floor is the bond value floor. $345M face, 2.5% coupon, 4.5 years remaining. At a distressed credit spread (600-800bps), the bond trades around $85-90 on the dollar. Conversion parity at $13.11 = par. Below $13, the convert trades on credit, implying a stock floor around $11-12 from bond math alone. That's the level where convert holders stop caring about equity and just hold for yield + par recovery.

Put OI at $13 strike (Mar 20 expiry): 1,894 contracts. At $12: 1,186. At $10: 1,456. Thin. No dealer gamma wall on the put side to provide support. Max pain at $14 for March — stock would need to fall 20% to get there.

The asymmetry is bearish. Forced sellers (Advent 23M shares, officer sales, convert arb unwind) are larger and more persistent than forced buyers (short squeeze requires sustained catalyst). Mechanical ceiling at $20-21 from capped call dealer hedging. No corresponding mechanical floor until ≈$11-12 from bond value.

One bullish insider signal: Director Blitzer (SPAC sponsor) bought 241K shares at $9.09 open market, $2.2M, Nov 2025. Only P-code purchase in LUNR history. But he's the SPAC sponsor — his $34M total holding is structural. Signal is genuine but conflicted.

Catalyst Map

No catalyst within 28 days forces repricing higher. The first real data point is Mar 23. Everything before that is positioning on narrative.

What I Got Wrong (Self-Audit)

This analysis went through seven stages including an explicit kill-your-thesis exercise. Findings:

1. ≈70% of the initial bearish analysis was consensus restated. The 21% short sellers already know about dilution, cash burn, and SPAC structure. Only two findings were genuinely differentiated: the Maxar segment financials (historical margin range of -5.1% to 6.2%) and the counterparty cross-reference (zero mentions by partners).

2. Initially anchored to worst-year base rate. Used FY2022 (-5.1%) as the Lanteris margin base rate — the worst year, during a distressed carve-out. FY2021 (6.2%) is the proper base. This changes the gap from "15-20pp miracle" to "4-8pp normal PE restructuring." Corrected: probability of margins <10% revised from 60% to 50%.

3. The pre-acquisition regression is methodologically broken. Applied standalone LUNR factor decomposition to evaluate a post-acquisition combined entity. The 65.9% idio / -3.4% alpha numbers describe a company that no longer exists.

4. Initially overweighted officer sales as bearish. Academic literature: director purchases > officer purchases > officer sales. The strongest insider signal (Blitzer's $2.2M buy) was bullish, not bearish. Updated.

5. Can't calculate alpha. Without verified Lanteris margins, no honest price target exists. Any target requires assuming the answer to the question that determines the answer.

Sizing

No position. Can't size what can't be calculated.

Alpha calculation requires:
  P_target = f(Lanteris GAAP margin)
  Lanteris GAAP margin = UNKNOWN until Mar 23

  Therefore:
  alpha = UNDEFINED
  position = 0

If Mar 23 reveals GAAP margins:

Bull scenario (margins genuinely 10%+):

• Combined EBITDA ≈$85-100M on $850M revenue
• EV/EBITDA 20-25x = EV $1.7-2.5B = ≈$18-22/share
• Alpha vs current: modest, consensus already prices this
• Edge required: demonstrate margins are SUSTAINABLE, not one-quarter

Bear scenario (margins sub-5%, adjusted metrics):

• Combined EBITDA ≈$20-40M or negative on GAAP basis
• EV/EBITDA 40x+ or negative = $8-12/share
• Alpha: -35% to -55% from current
• Catalyst: forced selling from Advent secondary, convert delta unwind

The bear scenario has more alpha IF it materializes because consensus is positioned bullish (7:1 buy/sell, $18.89 mean target). A margin miss reprices the stock harder than a margin beat re-rates it — the upside from "meeting expectations" is $18-22 from $17.55 (2-25% upside), while a miss is $8-12 (32-54% downside).

Prediction (Tracked)

50% probability that LUNR Q4 2025 earnings show Lanteris GAAP operating margin below 10%. Deadline: Apr 15, 2026.

Basis: Proper base rate is FY2021 at 6.2% (last normal year), not FY2022 at -5.1% (distressed transition). From 6.2%, achieving 10%+ requires 4-8pp improvement — normal PE restructuring range. Advent's selling posture (registration rights for 3 secondaries) suggests "improved enough to sell," which could be either side of 10%. Genuinely uncertain — this is a coin flip, not a lean.

After Mar 23: Decision Tree

If Lanteris GAAP operating margin > 10%:

• Management claim validated
• Run updated regression on combined entity
• Calculate alpha: target $20-22, modest from current
• Likely pass — consensus already there, limited upside vs risk

If Lanteris GAAP operating margin 5-10%:

• Partially validates turnaround, but "double-digit" was adjusted metric
• Stock likely sells off 10-20% to $14-16
• Potential entry if margin trajectory is improving quarter-over-quarter
• Need 2-3 quarters of data to confirm trend

If Lanteris GAAP operating margin < 5%:

• Historical base rate confirmed, PE turnaround failed or was overstated
• Stock drops 30-50% to $8-12
• Advent secondary accelerates as registration window opens
• Convert goes out-of-money, arb desks unwind
• SHORT candidate if borrow available and IV compresses post-earnings

If they don't break out Lanteris segment margins:

• First combined filing — management could report consolidated numbers only
• "We'll provide segment detail in Q1 2026" delays the catalyst by another quarter
• Stock likely trades sideways on ambiguity, IV compresses slightly but stays elevated
• This is the worst outcome for information — the binary stays unresolved
• No action. Wait another quarter. The thesis doesn't change, only the timeline.
• Probability: ≈20%. ASC 280 requires segment reporting for material acquisitions, and $800M is material. But "how much detail" is management's choice. They could give revenue by segment without margin detail, or use adjusted metrics that obscure GAAP profitability. The form of disclosure matters as much as the fact of it.

LR = 0.8 — Mild bearish. Analysis can't verify the one variable that matters, but the positioning is asymmetric: consensus is 7:1 bullish against a roughly 50/50 binary, with 2-3:1 downside/upside skew on miss vs beat. No informational edge, but the market's positioning creates a lean. Not actionable pre-catalyst.